Skip to main content
Fig. 5 | BMC Women's Health

Fig. 5

From: Efficacy and safety of vaginal suppositories containing combination of Natamycin and Lactulose in treatment of vulvovaginal candidiasis: international, randomized, controlled, superiority clinical trial (combination of Natamycin and Lactulose for treatment of vulvovaginal candidiasis)

Fig. 5

The number and proportion of patients with the overall recovery at Visit 2. The horizontal axis shows the number of patients with clinical and microscopic recovery in each group (Lactulose group, Natamycin + Lactulose group and Pimafucin group), the vertical axis shows the proportion (%) of patients

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us